Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/19 (What's New)

Summary

  • Doravirine is indicated in combination with other ARV agents for treatment of HIV infection in treatment-naive adult patients in United States[FDA Doravirine]
  • Also available as 1-pill once-daily regimen coformulated with lamivudine and tenofovir DF[FDA DOR/3TC/TDF]
  • Doravirine is administered at a dose of 100 mg once daily with or without food

    Action required

    Keywords: Dermatologic Complications, Initial Antiretroviral Therapy, Pregnancy, Special Populations, Treatment Complications

    ©2018 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.